Evidence map›Paper›PMID 32550185›Full record

ArticleJournal of diabetes and metabolic disorders2020

Antidiabetic activity of watermelon (

Basiru Olaitan Ajiboye, Moturayo Tawakalt Shonibare, Babatunji Emmanuel Oyinloye

Open access · greenAbstract read
In one paragraph

Article in Journal of diabetes and metabolic disorders, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Evaluating the Antidiabetic Activity ofTheScientificWorldJournal · 2025
    Article
  7. Article
  8. Review
  9. Nutrients · 2024
    Article
  10. Attenuation of PI3K/AKT signaling pathway byBiochemistry and biophysics reports · 2024
    Article
  11. Foods (Basel, Switzerland) · 2024
    Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Basiru Olaitan AjiboyeDepartment of Biochemistry, Phytomedicine and Nutraceutical Research Laboratory, College of Sciences, Afe Babalola University, Ado-Ekiti, Ekiti State Nigeria.
Moturayo Tawakalt ShonibareDepartment of Biochemistry, Phytomedicine and Nutraceutical Research Laboratory, College of Sciences, Afe Babalola University, Ado-Ekiti, Ekiti State Nigeria.
Babatunji Emmanuel OyinloyeDepartment of Biochemistry, Phytomedicine and Nutraceutical Research Laboratory, College of Sciences, Afe Babalola University, Ado-Ekiti, Ekiti State Nigeria.
Afe Babalola University · NGUniversity of Zululand · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionWatermelon is one of the commonly eaten fruit in most homes in Nigeria and has been used in the management of diabetes mellitus traditionally. This study was carried out to explore the antidiabetic potential of watermelon (

methodsWatermelon juice was used for the determination of in vitro parameters such as 1,1-diphenyl-2-picryl-hydrazil (DPPH), nitric oxide and ferric reducing antioxidant potential (FRAP) as well as phytochemicals such as total phenol, total flavonoids. In vitro

resultsThe watermelon juice exhibits anti-oxidant properties and inhibitory activities against α-glucosidase and α-amylase in a dose-dependent manner. Added to this, the administration of different doses of the watermelon juice significantly (

conclusionTaken together, this study demonstrates that watermelon (

Indexed as

Citrullus lanatusGlucose transportersMetforminα-amylaseα-glucosidase

Identifiers

PMID32550185
PMCPMC7270380
OpenAlexW3023967577

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.